Media coverage
2
Media coverage
Title APRINOIA Therapeutics Announces Fast Track Designation Granted By U.S. FDA To APN-1607 For The Diagnosis Of Progressive Supranuclear Palsy Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 21/05/24 Persons Howard Fillit Title APRINOIA Therapeutics Announces Fast Track Designation Granted By U.S. FDA To APN-1607 (Florzolotau) For The Diagnosis Of Progressive Supranuclear Palsy Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 20/05/24 Persons Howard Fillit